Utility of a Molecular Signature for Predicting Recurrence and Progression in Non-Muscle-Invasive Bladder Cancer Patients: Comparison with the EORTC, CUETO and 2021 EAU Risk Groups

To evaluate the utility of different risk assessments in non-muscle-invasive bladder cancer (NMIBC) patients, a total of 178 NMIBC patients from Chungbuk National University Hospital (CBNUH) were enrolled, and the predictive value of the molecular signature-based subtype predictor (MSP888) and risk...

Descripción completa

Detalles Bibliográficos
Autores principales: Piao, Xuan-Mei, Kim, Seon-Kyu, Byun, Young Joon, Zheng, Chuang-Ming, Kang, Ho Won, Kim, Won Tae, Kim, Yong-June, Lee, Sang-Cheol, Kim, Wun-Jae, Moon, Sung-Kwon, Choi, Yung Hyun, Yun, Seok Joong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9696895/
https://www.ncbi.nlm.nih.gov/pubmed/36430959
http://dx.doi.org/10.3390/ijms232214481

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9696895/
https://www.ncbi.nlm.nih.gov/pubmed/36430959
http://dx.doi.org/10.3390/ijms232214481

Ejemplares similares